124 related articles for article (PubMed ID: 38479278)
21. MUC1 and MUC2 expression in salivary gland tumors and in non-neoplastic salivary gland tissue.
Mannweiler S; Beham A; Langner C
APMIS; 2003 Oct; 111(10):978-84. PubMed ID: 14616551
[TBL] [Abstract][Full Text] [Related]
22. Epithelial membrane antigen and DOG1 expression in minor salivary gland tumours.
Andrade EP; Teixeira LN; Montalli VAM; Garcia FM; Passador-Santos F; Soares AB; Araújo VC
Ann Diagn Pathol; 2019 Dec; 43():151408. PubMed ID: 31629156
[TBL] [Abstract][Full Text] [Related]
23. Usefulness of the melanoma antigen gene (MAGE) in making the differential diagnosis between pleomorphic adenoma and adenoid cystic carcinoma.
Park JH; Do NY; Han SI; Lim SC
J Otolaryngol Head Neck Surg; 2012 Feb; 41(1):20-9. PubMed ID: 22498264
[TBL] [Abstract][Full Text] [Related]
24. Expression of HHLA2, TMIGD2, and GITR in salivary gland adenoid cystic carcinoma and mucoepidermoid carcinoma.
Zhang MJ; Wang S; Wu CC; Wu L; Sun ZJ
J Oral Pathol Med; 2022 Apr; 51(4):379-387. PubMed ID: 35226778
[TBL] [Abstract][Full Text] [Related]
25. Immunoexpression of GLUT-1 and angiogenic index in pleomorphic adenomas, adenoid cystic carcinomas, and mucoepidermoid carcinomas of the salivary glands.
de Souza LB; de Oliveira LC; Nonaka CFW; Lopes MLDS; Pinto LP; Queiroz LMG
Eur Arch Otorhinolaryngol; 2017 Jun; 274(6):2549-2556. PubMed ID: 28299426
[TBL] [Abstract][Full Text] [Related]
26. PCNA, Ki-67 and p53 expressions in submandibular salivary gland tumours.
Alves FA; Pires FR; De Almeida OP; Lopes MA; Kowalski LP
Int J Oral Maxillofac Surg; 2004 Sep; 33(6):593-7. PubMed ID: 15308260
[TBL] [Abstract][Full Text] [Related]
27. Immunoexpression of Autophagy-Related Proteins in Salivary Gland Tumors: An Exploratory Study.
Pires EG; Ferreira CR; Cavalcante RB; de Aguiar MCF; Mesquita RA; Alves PM; Nonaka CFW
Head Neck Pathol; 2023 Sep; 17(3):589-598. PubMed ID: 37118353
[TBL] [Abstract][Full Text] [Related]
28. Correlation of human Bub1 expression with tumor-proliferating activity in salivary gland tumors.
Shigeishi H; Yoneda S; Taki M; Nobumori T; Ohta K; Higashikawa K; Yasui W; Kamata N
Oncol Rep; 2006 Apr; 15(4):933-8. PubMed ID: 16525682
[TBL] [Abstract][Full Text] [Related]
29. Tumours of the lacrimal gland. Epidemiological, clinical and genetic characteristics.
von Holstein SL
Acta Ophthalmol; 2013 Nov; 91 Thesis 6():1-28. PubMed ID: 24893972
[TBL] [Abstract][Full Text] [Related]
30. High levels of ANXA2 are characteristic of malignant salivary gland tumors.
Cardoso CM; de Jesus SF; de Souza MG; Queiroz LDRP; Santos EM; Dos Santos EP; Oliveira LP; Cordeiro Santos CK; Santos SHS; de Paula AMB; Farias LC; Guimaraes ALS
J Oral Pathol Med; 2019 Nov; 48(10):929-934. PubMed ID: 31325182
[TBL] [Abstract][Full Text] [Related]
31. Human α-defensin (DEFA) gene expression helps to characterise benign and malignant salivary gland tumours.
Winter J; Pantelis A; Kraus D; Reckenbeil J; Reich R; Jepsen S; Fischer HP; Allam JP; Novak N; Wenghoefer M
BMC Cancer; 2012 Oct; 12():465. PubMed ID: 23050799
[TBL] [Abstract][Full Text] [Related]
32. MCM3 as a novel diagnostic marker in benign and malignant salivary gland tumors.
Ashkavandi ZJ; Najvani AD; Tadbir AA; Pardis S; Ranjbar MA; Ashraf MJ
Asian Pac J Cancer Prev; 2013; 14(6):3479-82. PubMed ID: 23886132
[TBL] [Abstract][Full Text] [Related]
33. E-CADERIN, N-CADERIN, SLUG, SNAIL, and TWIST contribute to epithelial-mesenchymal transition in salivary gland tumors.
de Santana DA; Braga PR; Camillo-Coutinho CM; Freitas VS; Cury PR; Ribeiro DA; de Araújo IB; de Aquino Xavier FC; Dos Santos JN
J Oral Pathol Med; 2024 Mar; 53(3):193-200. PubMed ID: 38351435
[TBL] [Abstract][Full Text] [Related]
34. A microRNA signature for the differential diagnosis of salivary gland tumors.
Denaro M; Navari E; Ugolini C; Seccia V; Donati V; Casani AP; Basolo F
PLoS One; 2019; 14(1):e0210968. PubMed ID: 30682201
[TBL] [Abstract][Full Text] [Related]
35. Squamous/epidermoid differentiation in normal breast and salivary gland tissues and their corresponding tumors originate from p63/K5/14-positive progenitor cells.
Boecker W; Stenman G; Loening T; Andersson MK; Berg T; Lange A; Bankfalvi A; Samoilova V; Tiemann K; Buchwalow I
Virchows Arch; 2015 Jan; 466(1):21-36. PubMed ID: 25344874
[TBL] [Abstract][Full Text] [Related]
36. Salivary gland-type tumors of the breast: a spectrum of benign and malignant tumors including "triple negative carcinomas" of low malignant potential.
Foschini MP; Krausz T
Semin Diagn Pathol; 2010 Feb; 27(1):77-90. PubMed ID: 20306833
[TBL] [Abstract][Full Text] [Related]
37. Distinct histone H3 modification profiles correlate with aggressive characteristics of salivary gland neoplasms.
Lam-Ubol A; Phattarataratip E
Sci Rep; 2022 Sep; 12(1):15063. PubMed ID: 36064736
[TBL] [Abstract][Full Text] [Related]
38. Immunohistochemical expression of progesterone receptors in pleomorphic adenoma and adenoid cystic carcinoma.
Safoura S; Mohamad E; Nosrat-Allah E; Fereshte E
J Cancer Res Ther; 2011; 7(1):23-8. PubMed ID: 21546738
[TBL] [Abstract][Full Text] [Related]
39. Human kallikrein 14 (KLK14) expression in salivary gland tumors.
Hashem NN; Mara TW; Mohamed M; Zhang I; Fung K; Kwan KF; Daley TD; Diamandis EP; Darling MR
Int J Biol Markers; 2010; 25(1):32-7. PubMed ID: 20155713
[TBL] [Abstract][Full Text] [Related]
40. LEF-1: Diagnostic utility in distinguishing basaloid neoplasms of the salivary gland.
Schmitt AC; Griffith CC; Cohen C; Siddiqui MT
Diagn Cytopathol; 2017 Dec; 45(12):1078-1083. PubMed ID: 28972308
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
